Company Filing History:
Years Active: 1994-2000
Title: John Gordon Dann: Innovator in Anti-Atherosclerotic Compounds
Introduction
John Gordon Dann is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of medical therapy, particularly in the development of compounds aimed at treating conditions such as hyperlipidaemia and atherosclerosis. With a total of 4 patents to his name, Dann's work has had a meaningful impact on pharmaceutical research.
Latest Patents
One of his latest patents focuses on anti-atherosclerotic diaryl compounds. This invention is concerned with diaryl compounds of a specific formula and their use in medical therapy. The compounds are particularly relevant for the prophylaxis or treatment of clinical conditions for which an ACAT inhibitor is indicated. This includes conditions like hyperlipidaemia and atherosclerosis. The invention also encompasses pharmaceutical compositions and processes for preparing these compounds.
Career Highlights
Throughout his career, John Gordon Dann has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. His experience in these organizations has contributed to his expertise in developing innovative medical therapies.
Collaborations
Dann has collaborated with notable individuals in his field, including Richard James Arrowsmith and Karl Witold Franzmann. These collaborations have likely enriched his research and development efforts.
Conclusion
John Gordon Dann's contributions to the field of medical therapy through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of treatments for critical health conditions.